Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 19602-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#19602-1-AP, RRID:AB_10642702
- Product name
- TRIP13 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TRIP13 antibody (Cat. #19602-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial-mesenchymal transition.
SKP1 drives the prophase I to metaphase I transition during male meiosis.
TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
The PSMA8 subunit of the spermatoproteasome is essential for proper meiotic exit and mouse fertility.
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
Li ZH, Lei L, Fei LR, Huang WJ, Zheng YW, Yang MQ, Wang Z, Liu CC, Xu HT
Journal of molecular histology 2021 Feb;52(1):11-20
Journal of molecular histology 2021 Feb;52(1):11-20
SKP1 drives the prophase I to metaphase I transition during male meiosis.
Guan Y, Leu NA, Ma J, Chmátal L, Ruthel G, Bloom JC, Lampson MA, Schimenti JC, Luo M, Wang PJ
Science advances 2020 Mar;6(13):eaaz2129
Science advances 2020 Mar;6(13):eaaz2129
TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
Agarwal S, Behring M, Kim HG, Chandrashekar DS, Chakravarthi BVSK, Gupta N, Bajpai P, Elkholy A, Al Diffalha S, Datta PK, Heslin MJ, Varambally S, Manne U
Molecular oncology 2020 Dec;14(12):3007-3029
Molecular oncology 2020 Dec;14(12):3007-3029
TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Di S, Li M, Ma Z, Guo K, Li X, Yan X
Pathology, research and practice 2019 Jun;215(6):152415
Pathology, research and practice 2019 Jun;215(6):152415
TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
Zhang G, Zhu Q, Fu G, Hou J, Hu X, Cao J, Peng W, Wang X, Chen F, Cui H
British journal of cancer 2019 Dec;121(12):1069-1078
British journal of cancer 2019 Dec;121(12):1069-1078
The PSMA8 subunit of the spermatoproteasome is essential for proper meiotic exit and mouse fertility.
Gómez-H L, Felipe-Medina N, Condezo YB, Garcia-Valiente R, Ramos I, Suja JA, Barbero JL, Roig I, Sánchez-Martín M, de Rooij DG, Llano E, Pendas AM
PLoS genetics 2019 Aug;15(8):e1008316
PLoS genetics 2019 Aug;15(8):e1008316
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Sheng N, Yan L, Wu K, You W, Gong J, Hu L, Tan G, Chen H, Wang Z
Cell death & disease 2018 Mar 14;9(3):402
Cell death & disease 2018 Mar 14;9(3):402
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
Banerjee R, Russo N, Liu M, Basrur V, Bellile E, Palanisamy N, Scanlon CS, van Tubergen E, Inglehart RC, Metwally T, Mani RS, Yocum A, Nyati MK, Castilho RM, Varambally S, Chinnaiyan AM, D'Silva NJ
Nature communications 2014 Jul 31;5:4527
Nature communications 2014 Jul 31;5:4527
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 19602-1-AP(TRIP13 antibody) at dilution of 1:400
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TRIP13 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human TRIP13. This antibody recognizes human,mouse,rat antigen. The TRIP13 antibody has been validated for the following applications: ELISA, WB, IP analysis.